(Q42451467)

31 October 2017

The role of p63 and deltaNp63 (p40) protein expression and gene amplification in esophageal carcinogenesis (English)

1 reference

31 October 2017

The role of p63 and ΔNp63 (p40) protein expression and gene amplification in esophageal carcinogenesis (English)

1 reference

https://api.crossref.org/works/10.1016/S0046-8177(03)00342-3

22 March 2024

1 reference

Helene Geddert

1

1 reference

31 October 2017

Sibylle Kiel

2

1 reference

31 October 2017

Hans Jörg Heep

3

1 reference

31 October 2017

Helmut Erich Gabbert

4

1 reference

31 October 2017

Mario Sarbia

5

1 reference

31 October 2017

language of work or name

English

0 references

publication date

1 September 2003

1 reference

full work available at URL

31 October 2017

https://api.elsevier.com/content/article/PII:S0046817703003423?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0046-8177(03)00342-3

https://api.elsevier.com/content/article/PII:S0046817703003423?httpAccept=text/plain

22 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0046-8177(03)00342-3

22 March 2024

1 reference

31 October 2017

34

1 reference

31 October 2017

9

1 reference

31 October 2017

850-856

1 reference

Role of the newer p53 family proteins in malignancy

31 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2803%2900342-3

7 January 2021

p53 associates with and targets Delta Np63 into a protein degradation pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2803%2900342-3

7 January 2021

AIS is an oncogene amplified in squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2803%2900342-3

7 January 2021

p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2803%2900342-3

7 January 2021

Association of p63 with proliferative potential in normal and neoplastic human keratinocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2803%2900342-3

7 January 2021

p63, a p53 homologue, is a selective nuclear marker of myoepithelial cells of the human breast

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2803%2900342-3

7 January 2021

p63 is a prostate basal cell marker and is required for prostate development

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2803%2900342-3

7 January 2021

Histologic and immunophenotypic classification of cervical carcinomas by expression of the p53 homologue p63: a study of 250 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2803%2900342-3

7 January 2021

Expression of p53-related protein p63 in the gastrointestinal tract and in esophageal metaplastic and neoplastic disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2803%2900342-3

7 January 2021

Expression of the p53 homologue p63alpha and DeltaNp63alpha in the neoplastic sequence of Barrett's oesophagus: correlation with morphology and p53 protein

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2803%2900342-3

7 January 2021

TP53 mutations, amplification of P63 and expression of cell cycle proteins in squamous cell carcinoma of the oesophagus from a low incidence area in Western Europe

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2803%2900342-3

7 January 2021

Observer variation in the diagnosis of dysplasia in Barrett's esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2803%2900342-3

7 January 2021

Gene amplification and overexpression of CDK4 in sporadic breast carcinomas is associated with high tumor cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2803%2900342-3

7 January 2021

High level expression of deltaN-p63: a mechanism for the inactivation of p53 in undifferentiated nasopharyngeal carcinoma (NPC)?

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2803%2900342-3

7 January 2021

Value of p63 and cytokeratin 5/6 as immunohistochemical markers for the differential diagnosis of poorly differentiated and undifferentiated carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2803%2900342-3

7 January 2021

Split-hand/split-foot malformation is caused by mutations in the p63 gene on 3q27.

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2803%2900342-3

7 January 2021

p63 is a p53 homologue required for limb and epidermal morphogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2803%2900342-3

7 January 2021

Frequent gain of the p40/p51/p63 gene locus in primary head and neck squamous cell carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2803%2900342-3

7 January 2021

Genetic alterations in esophageal cancer and their relevance to etiology and pathogenesis: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2803%2900342-3

7 January 2021

p63 expression profiles in human normal and tumor tissues

9

1 reference

https://api.crossref.org/works/10.1016/S0046-8177(03)00342-3

p63 expression is associated with p53 loss in oral-esophageal epithelia of p53-deficient mice

22 March 2024

28

1 reference

https://api.crossref.org/works/10.1016/S0046-8177(03)00342-3

Frequent alteration of p63 expression in human primary bladder carcinomas

22 March 2024

30

1 reference

https://api.crossref.org/works/10.1016/S0046-8177(03)00342-3

22 March 2024

Identifiers

1 reference

31 October 2017

1 reference